GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,000 | – | 3 | 0.0% | 0.00% | – |
Q4 2020 | $0 | – | 3 | 0.0% | 0.00% | – |
Q3 2020 | $0 | – | 3 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 3 | 0.0% | 0.00% | – |
Q1 2020 | $0 | – | 3 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 3 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 3 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 3 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | – | 3 | 0.0% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 3 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | – | 3 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 3 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 3 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 3 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 3 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 3 | 0.0% | 0.00% | – |
Q1 2017 | $0 | – | 3 | 0.0% | 0.00% | – |
Q4 2016 | $0 | – | 3 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 3 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 3 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 3 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 3 | 0.0% | 0.00% | – |
Q3 2015 | $0 | – | 3 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |